Patrys Ltd has released a press release.
Appendix 4C - Quarterly - 31 December 2017
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Patrys
- Publication and Patent Filing for Humanized Version of 3E10
- PAT-DX1-NP Localizes to Lymph Node Metastases
- Entitlement Offer Booklet
- PAT-DX1 is synergistic with PARP inhibitor
- Collaboration with WEHI
Later from Patrys
- Appendix 4D - Half Year Accounts - 31 December 2017
- PAT-DX1 Crosses Blood Brain Barrier to Reduce Tumour Size
- PAT-DX1 Improves Survival in Animal Model of Glioblastoma
- Appendix 4C - Quarterly - 31 March 2018
- Patrys Completes $3.5M Placement
Follow Patrys into a list and get an email when it puts out news.
Follow Patrys